In the future, it would be interesting to use the advantages of heterozygous Smad4 knockout CC mice to investigate additional phenotypes of MetS, such as insulin resistance, diabetes, and lipid metabolism, in addition to cancer susceptibility. Here, SMAD4 is linked to metabolic syndrome.